IFNA1 and lymphoma: Montico and Dal Col et al. developed monocyte-derived DCs generated in the presence of IFN-α and GM-CSF (IFN-α–conditioned DC) with highly immunogenic tumor cell lysates (TCLs) obtained from lymphoma cells undergoing ICD.